Trial · NCT07907770
Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease
NCT07907770, Not yet recruiting, University of Haifa
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease. Trials, record NCT07907770. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907770
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease
- NCT number
- NCT07907770
- Status
- Not yet recruiting
- Enrollment
- 120 participants, estimated
- Lead sponsor
- University of Haifa
- Conditions
- PARKINSON DISEASE (Disorder), Older Adults (65-85 Years)
- Interventions
- Obstacle Crossing Task
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 1. Judgment error | Baseline (single session, up to 2 hours) | Calculated as the absolute difference (in cm) between the estimated maximum obstacle height and the actual maximum height successfully crossed |
| Primary | 2. Normalized Estimated Maximum Obstacle Crossing Height | Baseline (single session, up to 2 hours) | The estimated maximum obstacle height the participant believes they can cross, normalized to the participant's leg length |
| Secondary | 1. Perceptual Error type (Over-estimation / Under-estimation) | Baseline (single session, up to 2 hours) | Categorized as over-estimation (actual performance \< estimated) or under-estimation (actual performance \> estimated) |
| Secondary | 2. Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III | Baseline (single session, up to 2 hours) | The evaluator assesses components such as bradykinesia, tremor, posture, and muscle rigidity. Higher scores indicate greater motor impairment. Assessed only in participants with Parkinson's disease |
| Secondary | 3. Levodopa Equivalent Dose (LED) | Baseline (single session, up to 2 hours) | A calculated value reflecting the weighted medication dosage for Parkinson's disease, serving as an indicator of disease severity. Assessed only in the Parkinson's disease group. |
| Secondary | 4. Timed Up and Go (TUG) Test | Baseline (single session, up to 2 hours) | The time (in seconds) it takes to rise from a chair, walk 3 meters, turn, return, and sit down is measured. Faster times indicate better functional mobility and lower fall risk |
| Secondary | 5. NeuroTrax™ - Global Cognitive Score (GCS) | Baseline (single session, up to 2 hours) | Assessed using the NeuroTrax™ computerized cognitive testing battery. Participants perform tasks testing attention, visuospatial processing, and executive functions. Results yield a GCS, where higher scores indicate better cognitive function |
| Secondary | 6. Self-Awareness of Falls Risk Measure (SAFRM) | Baseline (single session, up to 2 hours) | A measure assessing self-awareness of falls risk, consisting of identical patient and clinician versions across three sub-scales: Intellectual (15 items), Emergent (6 items, completed immediately after the Timed Up and Go test), and Anticipatory (10 items). The awareness score is calculated as the sum of the patient's scores minus the sum of the clinician's scores. A score of 0 indicates good awareness. A positive score indicates the patient overestimates their ability or underestimates the risk, while a negative score indicates the patient underestimates their ability or overestimates the risk |
| Secondary | 7. Geriatric Depression Scale (GDS-15) | Baseline (single session, up to 2 hours) | A 15-item questionnaire. Scores range from 0 to 15, with scores greater than 5 indicating a probability of depression |
| Secondary | 8. Activities-specific Balance Confidence (ABC) Scale | Baseline (single session, up to 2 hours) | Participants rate their confidence in performing daily activities without losing balance from 0% (no confidence) to 100% (complete confidence). The total score is the average of all items, with higher scores indicating greater confidence and less fear of falling |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907770
GET https://conductscience.org/api/trials/v1/NCT07907770/registered